Lipoproteins, platelets and atherothrombosis.

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Thrombosis Research

Background:

• Atherosclerosis and plaque rupture are primary causes of cardiovascular events like acute coronary syndrome.
• Low-density lipoprotein (LDL) is central to atherothrombotic pathogenesis.
• Vascular endothelium dysfunction and inflammation are key contributors.

Purpose of the Study:

• To review the role of native and modified LDL in atherothrombosis.
• To discuss LDL's impact on vascular and blood cells, especially platelets.
• To identify potential novel therapeutic targets related to LDL.

Main Methods:

• Literature review focusing on LDL's role in atherothrombosis.
• Analysis of LDL modifications (oxidation, aggregation, glycosylation).
• Examination of LDL's effects on endothelial nitric oxide, inflammation, and cell functions.

Main Results:

• Modified LDL enhances atherogenic properties, promoting foam cell formation and plaque vulnerability.
• LDL alters endothelial antithrombotic capacity and vascular contractility.
• LDL increases blood thrombogenicity by raising tissue factor and enhancing platelet reactivity.

Conclusions:

• Both native and modified LDL are critical in the pathogenesis of atherothrombosis.
• Understanding LDL's cellular effects highlights its significance in cardiovascular disease.
• Targeting LDL pathways presents potential therapeutic strategies for atherothrombosis.